| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
President, R&D | See Remarks
1 company
Bergstrom Donald A serves as a President, R&D at RLAY. Across recent SEC filings that breaks down to 0 buys and 62 sells. Those positions are worth an estimated $7.6M at current prices.
Historically, Bergstrom Donald A's trades have earned a strong insider score of 74/100 across 54 rated trades. Over a 12-month horizon, 80.8% of those trades were profitable, with an average 12-month return of +21.6%.
The biggest single holding is RLAY (~$7.6M) as President, R&D. The recent filings there lean toward selling, a net 651,439 shares.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep 8, 2026 | RLAY Relay Therapeutics, Inc. | President, R&D | Sell10b5-1 | 8,530 | $18.97 | $161,814.10 | -2.1% | - | - | |
| Jul 28, 2026 | RLAY Relay Therapeutics, Inc. | President, R&D | Sell | 2,237 | $18.61 | $41,630.57 | -0.5% | -0.6% | - | |
| Jul 6, 2026 | RLAY Relay Therapeutics, Inc. | President, R&D | Sell10b5-1 | 8,660 | $18.71 | $162,028.60 | -2.1% | +2.6% | - | |
| Jun 22, 2026 | RLAY Relay Therapeutics, Inc. | President, R&D | Sale+OE10b5-1 | 93,456 | $16.94 | $1,583,144.64 | -18.3% | +5.3% | - | |
| Apr 28, 2026 | RLAY Relay Therapeutics, Inc. | President, R&D | Sell | 1,490 | $14.79 | $22,037.10 | -0.4% | +43.1% | - | |
| Jan 28, 2026 | RLAY Relay Therapeutics, Inc. | President, R&D | Sell | 21,581 | $7.72 | $166,676.60 | -4.9% | +70.3% | - | |
| Oct 28, 2025 | RLAY Relay Therapeutics, Inc. | President, R&D | Sell | 30,897 | $7.29 | $225,239.13 | -5.6% | +0.9% | +141.8% | |
| Jul 29, 2025 | RLAY Relay Therapeutics, Inc. | President, R&D | Sell | 30,770 | $3.69 | $113,477.74 | -5.3% | +103.9% | +407.5% | |
| Apr 30, 2025 | RLAY Relay Therapeutics, Inc. | President, R&D | Sell | 31,562 | $3.02 | $95,381.30 | -5.1% | +8.7% | +289.2% | |
| Mar 27, 2025 | RLAY Relay Therapeutics, Inc. | President, R&D | Sell | 986 | $2.84 | $2,800.24 | -0.2% | +9.0% | +221.1% |